« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 10 of 40

Providence Cancer Institute expands outpatient services

March 09, 2018

From groundbreaking research to innovative treatments to compassionate care, everything we do at Providence Cancer Institute is for you, our patients. That’s why we’re expanding and consolidating outpatient cancer services on the 11th floor of our Robert W. Franz Cancer Center at Providence Portland Medical Center.

Adoptive T-cell transfer study opens for head and neck cancer patients

March 05, 2018

Adoptive T-cell transfer therapy is emerging as one of the most effective treatments to date for people with advanced melanoma. Now this treatment is available to patients with advanced or recurrent head and neck cancers through a clinical trial at Providence Cancer Institute.

New apalutamide study opens for prostate cancer

February 14, 2018

A new phase 3 study at Providence Cancer Institute will compare the effectiveness of three different treatment regimens in men with biochemically recurrent prostate cancer.

The Earle A. Chiles Research Institute Shines at SITC 2017 Annual Meeting

November 22, 2017

Walter J. Urba, M.D., Ph.D., Member, director and endowed chair, Earle A. Chiles Research Institute, Providence Cancer Institute The Earle A....

Providence Honors Early Advocate of Immunotherapy for Lifetime of Generosity and Service

October 03, 2017

In his lifetime and through his estate, the late Robert W. Franz gave close to $40 million to Providence Portland Medical Foundation. Providence Cancer Institute has been renamed in his honor.

Phase I research at Providence Cancer Institute

September 25, 2017
Phase I studies are the foundation for advancing cancer treatment with new agents and combinations of therapies. Providence Cancer Institute is often able to offer patients first-in-human clinical trials of novel cancer therapies through our own investigator-sponsored trials, and through collaborations with industry sponsors and other early-phase institutions around the country and worldwide.

Promising one-of-a-kind clinical trial adds immunotherapy to colorectal cancer treatment protocol

September 01, 2017

A first-of-its-kind clinical study may offer new hope to patients battling rectal cancer. The Phase 2 study, newly underway at Providence Cancer...

60 Minutes Australia features Patient 71, Julie Randall, and Providence Cancer Institute

July 10, 2017

With the release of her book Patient 71, Australia native Julie Randall has given cancer patients across the globe hope for life after cancer. Her remarkable story of overcoming stage IV metastatic melanoma was featured in a segment by 60 Minutes Australia chronicling her shocking diagnosis, promise to her family and determination to become “Patient 71” in an immunotherapy clinical trial at Providence Cancer Institute.

Julie Randall shares about life after cancer at Providence Creating Hope Dinner

June 30, 2017

Known as "Patient 71," persistence paid off for Australian cancer patient Julie Randall Learn more about her story › She now devotes her...

Members of the Earle A. Chiles Research Institute Garner Spotlight of ASCO and National Media

June 21, 2017

The Earle A. Chiles Research Institute, a division of Providence Cancer Center in Portland, Ore., was well-represented at the 2017 annual meeting of the American Society of Clinical Oncology held June 2-6 in Chicago, Ill. 

« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 10 of 40